Awakn Life Sciences Corp.

Not Rated
  • Market Cap: Micro Cap
  • Industry: Medical/Nursing Services
  • ISIN: CA05455W1086
CAD
0.11
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Awakn Life Sciences Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Jan'24
Jan'23
Jan'22
No of Months
12
12
12
Profit Before Tax
-3.00
-4.00
-16.00
Adjustment
0.00
0.00
0.00
Changes In working Capital
1.00
0.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
Cash Flow from Operating Activities
-2.00
-7.00
-8.00
Cash Flow from Investing Activities
0.00
0.00
-1.00
Cash Flow from Financing Activities
2.00
6.00
11.00
Net Cash Inflow / Outflow
0.00
-1.00
1.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
Figures in CAD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Awakn Life Sciences Corp.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(CAD)
Change(%)
Profit Before Tax
-3.671075
-2.71301
-1.00
-35.31%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
1.178373
0.158154
1.00
645.08%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-2.381416
-2.459164
0.00
3.16%
Cash Flow from Investing Activities
-0.020406
-0.005115
0.00
-298.94%
Cash Flow from Financing Activities
2.456046
0.587052
2.00
318.37%
Net Cash Inflow / Outflow
0.040749
-1.877227
1.00
102.17%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.013475
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Jan'24
stock-summary

YoY Growth in year ended Jan 2024 is 67.66% vs 14.24% in Jan 2023

Jan'24
Jan'23
Change(%)
Cash Flow from Operating Activities
-2.38
-7.36
67.66%